Clin2
NCT06913712Possibly a fitRecruiting

BMI and treatment response in IIH

Idiopathic Intracranial Hypertension (IIH)

Part of Brain & nervous system clinical trials.

This study looks at how body weight (BMI) affects how well people with Idiopathic Intracranial Hypertension (IIH) respond to treatment. It may help doctors understand if weight influences symptom relief.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
25 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older (no upper age limit).
  • You have a confirmed diagnosis of Idiopathic Intracranial Hypertension (IIH) using the Dandy criteria.
  • Doctors have ruled out other causes of high pressure in your skull, like a brain tumor, blood clot, or certain medicines.
  • You do not have a different headache disorder such as tension-type headache or Chiari I malformation.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06919744Recruiting
Stenting for intracranial hypertension: early treatment study

This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.

Montpellier
NCT07191873Recruiting· Phase 4
Tirzepatide for treating high pressure in the brain

This trial tests if tirzepatide can help lower the pressure inside your skull caused by a condition called Idiopathic Intracranial Hypertension. It's designed for people with a BMI of 30 or higher who have swelling of the optic nerve.

Durham, North Carolina
NCT07645833Not yet recruiting· Phase 3
Eptinezumab for chronic headache in intracranial hypertension

This trial tests whether eptinezumab, a medication that reduces a brain chemical called CGRP (involved in migraines), can help reduce headaches in people with idiopathic intracranial hypertension (IIH)—a condition where pressure builds up around the brain. The study wants to see if this treatment safely reduces headache frequency and severity.

NCT06950099Recruiting
Advanced Brain Scans for IIH Patients Planning Stenting

This study uses advanced brain scans (MRIs) to look at the veins in your brain to help plan a stenting procedure for patients with Idiopathic Intracranial Hypertension (IIH) that is not improving with standard care.

Philadelphia, Pennsylvania
NCT06833424Not yet recruiting
Stent for pressure in the head (idiopathic intracranial hypertension)

This trial tests if a small tube called a stent can be placed in a vein in your brain to relieve high pressure. It may help people with headaches, vision changes, or other symptoms from this condition.

Asyut
NCT06945848Recruiting
Stenting for Intracranial Hypertension on Acetazolamide

This trial tests whether placing a stent (a small tube) in a narrowed brain vein can help reduce pressure in the head in people with Intracranial Hypertension who have been on acetazolamide for over a year. It may be an option if you still have high pressure despite medication.

Montpellier

Hear when a new Idiopathic Intracranial Hypertension (IIH) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.